This streamlined approach not only accelerates the drug discovery pipeline but also improves the overall success rate of identifying viable drug targets. The AI-Powered Target Identification Service ...

Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Among the investors is GlaxoSmithKline, which is teaming up with the biotech startup in a multi-target ... rare disease drug discovery. The founders of Vesalius Therapeutics say AI and machine ...

Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...

Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.

Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

Tiny Michigan biotech startup CircNova has raised a $3.3 million seed round for its technology that uses AI to target “circular ... for how to use it with AI drug discovery.

Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing ...

Valo Health, Inc. ("Valo"), a biotechnology company focused on transforming the drug discovery and development process using ...